Arabinogalactan in Clinical Use

Rajendra P. Pawar; Babasaheb A. Kushekar; Bhaskar S. Jadhav; Kiran R. Kharat; Ravikumar M. Borade; Abraham J. Domb

doi:10.1002/9781118015810.ch7

Arabinogalactan in Clinical Use

Rajendra P. Pawar^*
, Babasaheb A. Kushekar
, Bhaskar S. Jadhav
, Kiran R. Kharat
, Ravikumar M. Borade
, Abraham J. Domb

^*Corresponding author for this work

School of Pharmacy

Research output: Chapter in Book/Report/Conference proceeding › Chapter › peer-review

9 Scopus citations

Original language	English
Title of host publication	Biodegradable Polymers in Clinical Use and Clinical Development
Publisher	John Wiley and Sons
Pages	217-245
Number of pages	29
ISBN (Print)	9780470424759
DOIs	https://doi.org/10.1002/9781118015810.ch7
State	Published - 3 May 2011

Keywords

Arabinogalactan biosynthesis in mycobateria tuberculosis - three steps
Arabinogalactan in clinical use, biologically active arabinogalactan - isolated from roots of Angelica acutiloba
Natural killer (NK) cytotoxicity, and human NK cytotoxicity - "the ability of spontaneous cytotoxicity against tumor and virus-infected cells"

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

Access to Document

10.1002/9781118015810.ch7

Cite this

@inbook{2c302c3255374b5b9e44499411c093d6,

title = "Arabinogalactan in Clinical Use",

keywords = "Arabinogalactan biosynthesis in mycobateria tuberculosis - three steps, Arabinogalactan in clinical use, biologically active arabinogalactan - isolated from roots of Angelica acutiloba, Natural killer (NK) cytotoxicity, and human NK cytotoxicity - {"}the ability of spontaneous cytotoxicity against tumor and virus-infected cells{"}",

author = "Pawar, \{Rajendra P.\} and Kushekar, \{Babasaheb A.\} and Jadhav, \{Bhaskar S.\} and Kharat, \{Kiran R.\} and Borade, \{Ravikumar M.\} and Domb, \{Abraham J.\}",

year = "2011",

month = may,

day = "3",

doi = "10.1002/9781118015810.ch7",

language = "אנגלית",

isbn = "9780470424759",

pages = "217--245",

booktitle = "Biodegradable Polymers in Clinical Use and Clinical Development",

publisher = "John Wiley and Sons",

}

TY - CHAP

T1 - Arabinogalactan in Clinical Use

AU - Pawar, Rajendra P.

AU - Kushekar, Babasaheb A.

AU - Jadhav, Bhaskar S.

AU - Kharat, Kiran R.

AU - Borade, Ravikumar M.

AU - Domb, Abraham J.

PY - 2011/5/3

Y1 - 2011/5/3

KW - Arabinogalactan biosynthesis in mycobateria tuberculosis - three steps

KW - Arabinogalactan in clinical use, biologically active arabinogalactan - isolated from roots of Angelica acutiloba

KW - Natural killer (NK) cytotoxicity, and human NK cytotoxicity - "the ability of spontaneous cytotoxicity against tumor and virus-infected cells"

UR - https://www.scopus.com/pages/publications/84886563560

U2 - 10.1002/9781118015810.ch7

DO - 10.1002/9781118015810.ch7

M3 - ???researchoutput.researchoutputtypes.contributiontobookanthology.chapter???

AN - SCOPUS:84886563560

SN - 9780470424759

SP - 217

EP - 245

BT - Biodegradable Polymers in Clinical Use and Clinical Development

PB - John Wiley and Sons

ER -

Arabinogalactan in Clinical Use

Keywords

UN SDGs

Access to Document

Other files and links

Cite this